Analytical Data
-
Gene name
C17orf85
- Application
-
Alternative Names
C17orf85; Chromosome 17 open reading frame 85; CQ085_HUMAN; ELG; HSA277841; Protein ELG; Uncharacterized Protein C17orf85
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q53F19
-
Expression Region
1-340aa
-
AA Sequence
MKYGNPNYGGMKGILSNSWKRRYHSRRIQRDVIKKRALIGDDVGLTSYKHRHSGLVNVPEEPIEEEEEEEEEEEEEEEEDQDMDADDRVVVEYHEELPALKQPRERSASRRSSASSSDSDEMDYDLELKMISTPSPKKSMKMTMYADEVESQLKNIRNSMRADSVSSSNIKNRIGNKLPPEKFADVRHLLDEKRQHSRPRPPVSSTKSDIRQRLGKRPHSPEKAFSSNPVVRREPSSDVHSRLGVPRQDSKGLYADTREKKSGNLWTRLGSAPKTKEKNTKKVDHRAPGAEEDDSELQRAWGALIKEKEQSRQKKSRLDNLPSLQIEVSRESSSGSEAES
-
Molecular Weight
65.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C17orf85, also known as chromosome 17 open reading frame 85, has garnered attention in recent years due to its potential roles in cellular processes and disease mechanisms. Initial studies suggested that this protein is involved in vital biological activities, including cell proliferation, differentiation, and apoptosis, which are crucial for maintaining homeostasis in various tissues. Notably, aberrations in the expression or function of C17orf85 have been implicated in several cancers and genetic disorders, prompting researchers to explore its molecular functions further. Recent advances in recombinant protein technology have enabled researchers to produce C17orf85 in sufficient quantities for structural and functional analysis, facilitating the investigation of its interactions with other cellular components. Understanding the structure and function of C17orf85 is essential, as it may serve as a potential biomarker for disease and a target for therapeutic interventions. Furthermore, studies have indicated that C17orf85 may interact with key signaling pathways, thus contributing to the understanding of its role in tumorigenesis and other pathological conditions. This growing body of evidence highlights the need for systematic studies on C17orf85, paving the way for potential clinical applications in the future.
